133 related articles for article (PubMed ID: 23638433)
1. Angiography reveals early hiding iris neovascularization after ischemic CRVO.
Li ZQ; Zhou XX; Lin S; Li JL; Wu JG
Int J Ophthalmol; 2013; 6(2):253-4. PubMed ID: 23638433
[No Abstract] [Full Text] [Related]
2. Central retinal vein occlusion, an investigation by color Doppler imaging. Blood velocity characteristics and prediction of iris neovascularization.
Williamson TH; Baxter GM
Ophthalmology; 1994 Aug; 101(8):1362-72. PubMed ID: 7520147
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of panretinal laser in ischemic central retinal vein occlusion: A systematic review.
Li C; Wang R; Liu G; Ge Z; Jin D; Ma Y; Liu G
Exp Ther Med; 2019 Jan; 17(1):901-910. PubMed ID: 30651879
[TBL] [Abstract][Full Text] [Related]
4. The effect of antivascular endothelial growth factor therapy on the development of neovascular glaucoma after central retinal vein occlusion: a retrospective analysis.
Ryu CL; Elfersy A; Desai U; Hessburg T; Edwards P; Gao H
J Ophthalmol; 2014; 2014():317694. PubMed ID: 24800060
[TBL] [Abstract][Full Text] [Related]
5. Panretinal photocoagulation and photodynamic therapy for anterior segment neovascularization secondary to ischemic central retinal vein occlusion.
Parodi MB; Friberg TR; Pedio M; Fiotti N; Di Stefano G; Ravalico G
Ophthalmic Surg Lasers Imaging; 2007; 38(2):94-9. PubMed ID: 17396687
[TBL] [Abstract][Full Text] [Related]
6. Neovascular events in eyes with central retinal vein occlusion undergoing serial bevacizumab or ranibizumab intravitreal injections: a retrospective review.
DeCroos FC; Todorich B; Alshareef R; Khuthaila M; Fekrat S; Ho AC; Regillo CD; Spirn MJ
J Ophthalmic Vis Res; 2014; 9(4):461-8. PubMed ID: 25709772
[TBL] [Abstract][Full Text] [Related]
7. USE OF THE ISCHEMIC INDEX ON WIDEFIELD FLUORESCEIN ANGIOGRAPHY TO CHARACTERIZE A CENTRAL RETINAL VEIN OCCLUSION AS ISCHEMIC OR NONISCHEMIC.
Thomas AS; Thomas MK; Finn AP; Fekrat S
Retina; 2019 Jun; 39(6):1033-1038. PubMed ID: 29474305
[TBL] [Abstract][Full Text] [Related]
8. Hyperacute iris neovascularization following cataract surgery.
Sim HE; Hwang JH
Medicine (Baltimore); 2022 Jul; 101(27):e29356. PubMed ID: 35801772
[TBL] [Abstract][Full Text] [Related]
9. Aqueous Inflammation and Ischemia-Related Biomarkers in Neovascular Glaucoma with Stable Iris Neovascularization.
Sun C; Zhang H; Tang Y; Chen Y; Li Y; Nie C; Gu J; Luo L; Wang Z
Curr Eye Res; 2020 Dec; 45(12):1504-1513. PubMed ID: 32339463
[No Abstract] [Full Text] [Related]
10. Role of the vitreous in central retinal vein occlusion.
Hikichi T; Konno S; Trempe CL
Retina; 1995; 15(1):29-33. PubMed ID: 7754244
[TBL] [Abstract][Full Text] [Related]
11. A grading system for iris neovascularization. Prognostic implications for treatment.
Teich SA; Walsh JB
Ophthalmology; 1981 Nov; 88(11):1102-6. PubMed ID: 6174915
[TBL] [Abstract][Full Text] [Related]
12. Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study.
Hayreh SS; Klugman MR; Podhajsky P; Servais GE; Perkins ES
Graefes Arch Clin Exp Ophthalmol; 1990; 228(4):281-96. PubMed ID: 1698170
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: a prospective study.
Rouvas A; Petrou P; Vergados I; Pechtasides D; Liarakos V; Mitsopoulou M; Ladas I
Graefes Arch Clin Exp Ophthalmol; 2009 Dec; 247(12):1609-16. PubMed ID: 19609550
[TBL] [Abstract][Full Text] [Related]
14. [Results of laser coagulation of central retinal vein occlusion].
Lang GE
Klin Monbl Augenheilkd; 1993 Oct; 203(4):247-51. PubMed ID: 7509425
[TBL] [Abstract][Full Text] [Related]
15. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study.
Feltgen N; Junker B; Agostini H; Hansen LL
Ophthalmology; 2007 Apr; 114(4):716-23. PubMed ID: 17141322
[TBL] [Abstract][Full Text] [Related]
16. The role of optical coherence tomography angiography in distinguishing ischemic versus non-ischemic central retinal vein occlusion.
An W; Zhao Q; Yu R; Han J
BMC Ophthalmol; 2022 Oct; 22(1):413. PubMed ID: 36307778
[TBL] [Abstract][Full Text] [Related]
17. Angiographic changes in iris and iridocorneal angle neovascularization after intravitreal bevacizumab injection.
Ishibashi S; Tawara A; Sohma R; Kubota T; Toh N
Arch Ophthalmol; 2010 Dec; 128(12):1539-45. PubMed ID: 21149776
[TBL] [Abstract][Full Text] [Related]
18. Retinochoroidal collateral veins protect against anterior segment neovascularization after central retinal vein occlusion.
Fuller JJ; Mason JO; White MF; McGwin G; Emond TL; Feist RM
Arch Ophthalmol; 2003 Mar; 121(3):332-6. PubMed ID: 12617702
[TBL] [Abstract][Full Text] [Related]
19. Verteporfin photodynamic therapy for anterior segment neovascularization secondary to ischaemic central retinal vein occlusion.
Parodi MB; Iacono P; Ravalico G
Clin Exp Ophthalmol; 2008 Apr; 36(3):232-7. PubMed ID: 18412591
[TBL] [Abstract][Full Text] [Related]
20. Interventions for central retinal vein occlusion: an evidence-based systematic review.
Mohamed Q; McIntosh RL; Saw SM; Wong TY
Ophthalmology; 2007 Mar; 114(3):507-19, 524. PubMed ID: 17324695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
